Chairman and CEO Patrick K. Donnelly today announced the official launch of Aptiv Solutions, a global biopharmaceutical and medical device development services company. The Company has integrated the resources and expertise of Averion International, Fulcrum Pharma, and ClinResearch, these companies now become Aptiv Solutions. In addition, ADDPLAN, the developer of advanced adaptive trial software products, will be a unit of the new company. Trio Clinical Resourcing, a dedicated staffing and functional outsourcing provider, and Niphix, a specialty oncology CRO in Japan, will operate as subsidiaries of Aptiv Solutions.
